Compare CRIS & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRIS | REE |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 17.1M |
| IPO Year | 2000 | 2021 |
| Metric | CRIS | REE |
|---|---|---|
| Price | $0.37 | $0.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 446.3K | 249.5K |
| Earning Date | 05-07-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | $27.10 | $327.73 |
| Revenue Next Year | $67.74 | $36,888.82 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.38 | $0.18 |
| 52 Week High | $2.48 | $1.76 |
| Indicator | CRIS | REE |
|---|---|---|
| Relative Strength Index (RSI) | 31.80 | 23.30 |
| Support Level | N/A | N/A |
| Resistance Level | $0.57 | $0.47 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 3.16 | 11.83 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.